Hutch News
Results per Page:
Infectious Diseases Society to honor Dr. Michael Boeckh
Hutch virus expert to deliver John F. Enders Lecture at Washington, D.C., conference
Mystery solved: How graft-vs.-host disease starts in the gut
Microbiome triggers top killer after bone marrow transplant — and there’s a potential way to stop it
Former WSJ health columnist tells her story of cancer survival
After treatment at Fred Hutch, Laura Landro inspired to empower patients via health and medicine journalism
Remembering transplant immunologist Dr. John Hansen
Physician-scientist defined rules for matching bone marrow transplant donors and patients, was a founding father of volunteer donor registries
Eight promising projects win Evergreen Fund grants to promote commercialization of research
A dozen scientists to receive up to $200K from 3-year-old Fred Hutch program
The New Yorker spotlights Fred Hutch’s pioneering cancer research
‘The Promise and Price of Cellular Therapies’ by Siddhartha Mukherjee traces journey from bone marrow transplantation to immunotherapy
Leukemia research leader Dr. Fred Appelbaum named ‘Giant of Cancer Care’
Physician-scientist and Hutch VP honored for contributions to research, patient care
Radiation dose and cancer risk after bone marrow transplant
High-dose radiation, younger age increase risk of developing subsequent cancer, new study finds
Dr. Robert Hickman, inventor of Hickman catheter, dies at age 92
Lifesaving device was ‘a gift to the world,’ former colleagues say
Scientists learn how common virus reactivates after transplantation
New Science paper describes how antibody-producing B cells, not disease-fighting T cells, protect against reactivation of cytomegalovirus
.jpg)
Rethinking an old viral foe
Why does a common virus plague bone marrow transplant patients? New study challenges dogma, opens door to new therapies.
Bone marrow transplant survival rates recognized nationally
Fred Hutch BMT program at SCCA earns national recognition for 6th consecutive year
Fred Hutch at ASH: Combo CAR T-cell therapies, long-term outcomes for CAR T patients, early findings on a CAR T for multiple myeloma, gene therapy for sickle cell, and T cells and the microbiome
The 60th American Society of Hematology Annual Meeting will take place Dec. 1–4 in San Diego
Dr. Marie Bleakley named Gerdin Family Endowed Chair for Leukemia Research
Pediatric cancer physician-scientist feted at rooftop reception
The legacy of a pioneering transplant immunologist
‘So much to be learned’: Dr. John Hansen reflects on the lives he’s saved and the answers still to come
3 big new leukemia research projects advance cutting-edge cell therapies, stem cell transplant
$20M renewal of 4-decade-long federal grant to Hutch scientists
Physician assistant Debra Mattson to retire May 24
She has been the historian — and the heart —of the Infectious Disease Consult Service
Seattle Times' Pacific NW Magazine profiles Fred Hutch
Seattle Times’ Sunday feature looks at the melding of expertise, drive and technology making new cures possible